Skip to main content
. 2016 Aug 25;52(4):1511–1533. doi: 10.1111/1475-6773.12547

Table 2.

Association of Medication Adherence with Enabling/Impeding Factors, Predisposing Factors and Need(Risk) Factors, Shown as Adjusted Odds Ratio and 95% Confidence Intervals

Explanatory Factors Adjusted Odds Ratio (95% Confidence Interval)
Enabling/impeding factors
OOP cost for statin medications 1.07 (1.057; 1.082)
Count of pharmacies per square mile in ZCTA 1.00 (0.999; 1.000)
Predisposing factors
Gender, male=yes 0.89 (0.854; 0.923)
Age, in years 0.97 (0.963; 0.968)
Rural ZCTAs 1.00 (0.921; 1.088)
ZCTAs where percentage households getting public assistance is at
1st quartile Reference
2nd quartile 1.08 (1.020; 1.152)
3rd quartile 1.09 (0.999; 1.199)
4th quartile 1.10 (0.980; 1.233)
ZCTAs where percentage population with less than high school education is at
1st quartile Reference
2nd quartile 1.00 (0.914; 1.083)
3rd quartile 0.94 (0.845; 1.038)
4th quartile 1.01 (0.877; 1.171)
ZCTAs where percentage population with college or higher education is at
1st quartile Reference
2nd quartile 0.97 (0.893; 1.058)
3rd quartile 0.88 (0.790; 0.973)
4th quartile 0.79 (0.690; 0.901)
ZCTAs where percentage of English‐only speaking population is at
1st quartile Reference
2nd quartile 0.96 (0.832; 1.118)
3rd quartile 1.00 (0.847; 1.174)
4th quartile 0.93 (0.773; 1.118)
Race/ethnicity
Non‐Hispanic white dominated ZCTAs Reference
Hispanic dominated ZCTAs 1.33 (1.140; 1.545)
African American dominated ZCTAs 1.56 (1.364; 1.787)
ZCTAs where foreign‐born population density is at
1st quartile Reference
2nd quartile 1.06 (0.961; 1.170)
3rd quartile 1.09 (0.974; 1.226)
4th quartile 1.20 (1.032; 1.399)
ZCTAs where average travel‐to‐work time is at
1st quartile Reference
2nd quartile 1.01 (0.939; 1.094)
3rd quartile 1.06 (0.980; 1.145)
4th quartile 1.15 (1.075; 1.233)
Need/risk factors
Comorbid conditions
Proportion of patients with diabetes 1.13 (1.077; 1.182)
Proportion of patients with mental disorders 1.11 (1.059; 1.163)
Proportion of patients with cardiovascular disorders 0.88 (0.842; 0.926)
Individuals who visited cardiologist 30 days before starting statin medications 0.79 (0.743; 0.845)
Prior health care utilization: total medical costs 6 months prior to starting statins
Low utilizers 1.11 (1.043; 1.175)
Intermediate utilizers Reference
High utilizers 1.04 (0.993; 1.087)
Constant 5.71 (4.217; 7.719)

Values set in bold font are statistically significant (p‐value < .05).